Literature DB >> 33994710

New Developments in the Treatment of Hepatocellular Carcinoma: The Concept of Adjuvant and Neoadjuvant Chemotherapy.

Anil C Anand1, Subrat K Acharya2,3.   

Abstract

Entities:  

Keywords:  CA, Cryoablation; HCC, Hepatocellular carcinoma; ICI, Immune checkpoint inhibitor; LT, Liver transplantation; MKI, Multikinase inhibitor; MWA, Microwave ablation; RFA, Radiofrequency ablation; TACE, Transarterial chemoembolization

Year:  2021        PMID： 33994710      PMCID： PMC8103336          DOI： 10.1016/j.jceh.2021.04.003

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN： 0973-6883


× No keyword cloud information.
  40 in total

1.  Radiofrequency Ablation vs. Cryoablation for Localized Hepatocellular Carcinoma: A Propensity-matched Population Study.

Authors:  Jimmy Xu; Christopher Noda; Abigail Erickson; Mahati Mokkarala; Resmi Charalel; Raja Ramaswamy; Y U Tao; Olaguoke Akinwande
Journal:  Anticancer Res       Date:  2018-11       Impact factor: 2.480

2.  Batf3+ DCs and type I IFN are critical for the efficacy of neoadjuvant cancer immunotherapy.

Authors:  Jing Liu; Elisa A Rozeman; Jake S O'Donnell; Stacey Allen; Lorenzo Fanchi; Mark J Smyth; Christian U Blank; Michele W L Teng
Journal:  Oncoimmunology       Date:  2018-11-22       Impact factor: 8.110

Review 3.  2019 Update of Indian National Association for Study of the Liver Consensus on Prevention, Diagnosis, and Management of Hepatocellular Carcinoma in India: The Puri II Recommendations.

Authors:  Ashish Kumar; Subrat K Acharya; Shivaram P Singh; Anil Arora; Radha K Dhiman; Rakesh Aggarwal; Anil C Anand; Prashant Bhangui; Yogesh K Chawla; Siddhartha Datta Gupta; Vinod K Dixit; Ajay Duseja; Naveen Kalra; Premashish Kar; Suyash S Kulkarni; Rakesh Kumar; Manoj Kumar; Ram Madhavan; V G Mohan Prasad; Amar Mukund; Aabha Nagral; Dipanjan Panda; Shashi B Paul; Padaki N Rao; Mohamed Rela; Manoj K Sahu; Vivek A Saraswat; Samir R Shah; Praveen Sharma; Sunil Taneja; Manav Wadhawan
Journal:  J Clin Exp Hepatol       Date:  2019-09-23

Review 4.  Recent Advances in Systemic Therapy for Hepatocellular Carcinoma in an Aging Society: 2020 Update.

Authors:  Masatoshi Kudo
Journal:  Liver Cancer       Date:  2020-11-17       Impact factor: 11.740

5.  Intratumoral Tcf1+PD-1+CD8+ T Cells with Stem-like Properties Promote Tumor Control in Response to Vaccination and Checkpoint Blockade Immunotherapy.

Authors:  Imran Siddiqui; Karin Schaeuble; Vijaykumar Chennupati; Silvia A Fuertes Marraco; Sandra Calderon-Copete; Daniela Pais Ferreira; Santiago J Carmona; Leonardo Scarpellino; David Gfeller; Sylvain Pradervand; Sanjiv A Luther; Daniel E Speiser; Werner Held
Journal:  Immunity       Date:  2019-01-08       Impact factor: 31.745

6.  Increased expression of vascular endothelial growth factor in hepatocellular carcinoma after transcatheter arterial chemoembolization.

Authors:  B Wang; H Xu; Z Q Gao; H F Ning; Y Q Sun; G W Cao
Journal:  Acta Radiol       Date:  2008-06       Impact factor: 1.990

7.  TACE Treatment in Patients with Sorafenib-treated Unresectable Hepatocellular Carcinoma in Clinical Practice: Final Analysis of GIDEON.

Authors:  Jean-François Geschwind; Masatoshi Kudo; Jorge A Marrero; Alan P Venook; Xiao-Ping Chen; Jean-Pierre Bronowicki; Lucy Dagher; Junji Furuse; Laura Ladrón de Guevara; Christos Papandreou; Arun J Sanyal; Tadatoshi Takayama; Sheng-Long Ye; Seung Kew Yoon; Keiko Nakajima; Robert Lehr; Stephanie Heldner; Riccardo Lencioni
Journal:  Radiology       Date:  2016-01-08       Impact factor: 11.105

8.  A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanoma.

Authors:  Alexander C Huang; Robert J Orlowski; Xiaowei Xu; Rosemarie Mick; Sangeeth M George; Patrick K Yan; Sasikanth Manne; Adam A Kraya; Bradley Wubbenhorst; Liza Dorfman; Kurt D'Andrea; Brandon M Wenz; Shujing Liu; Lakshmi Chilukuri; Andrew Kozlov; Mary Carberry; Lydia Giles; Melanie W Kier; Felix Quagliarello; Suzanne McGettigan; Kristin Kreider; Lakshmanan Annamalai; Qing Zhao; Robin Mogg; Wei Xu; Wendy M Blumenschein; Jennifer H Yearley; Gerald P Linette; Ravi K Amaravadi; Lynn M Schuchter; Ramin S Herati; Bertram Bengsch; Katherine L Nathanson; Michael D Farwell; Giorgos C Karakousis; E John Wherry; Tara C Mitchell
Journal:  Nat Med       Date:  2019-02-25       Impact factor: 53.440

9.  Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial.

Authors:  Masatoshi Kudo; Kazuomi Ueshima; Masafumi Ikeda; Takuji Torimura; Nobukazu Tanabe; Hiroshi Aikata; Namiki Izumi; Takahiro Yamasaki; Shunsuke Nojiri; Keisuke Hino; Hidetaka Tsumura; Teiji Kuzuya; Norio Isoda; Kohichiroh Yasui; Hajime Aino; Akio Ido; Naoto Kawabe; Kazuhiko Nakao; Yoshiyuki Wada; Osamu Yokosuka; Kenichi Yoshimura; Takuji Okusaka; Junji Furuse; Norihiro Kokudo; Kiwamu Okita; Philip James Johnson; Yasuaki Arai
Journal:  Gut       Date:  2019-12-04       Impact factor: 23.059

Review 10.  Locoregional treatments for hepatocellular carcinoma: Current evidence and future directions.

Authors:  Riccardo Inchingolo; Alessandro Posa; Martin Mariappan; Stavros Spiliopoulos
Journal:  World J Gastroenterol       Date:  2019-08-28       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.